Healthcare & Life Sciences
Oxford BioTherapeutics
United Kingdomwww.oxfordbiotherapeutics.com
Oxford BioTherapeutics is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Seed, 3 tracked investors.
Activeseed
seed
Stage
2015
Founded
3
Investors
About Oxford BioTherapeutics
Oxford BioTherapeutics is a company founded in 2015 headquartered in the United Kingdom. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Oxford BioTherapeutics is a clinical-stage oncology company developing first-in-class antibody-based therapies, including Antibody-Drug Conjugates (ADCs) and T-cell engagers (TCEs), to improve patient outcomes in cancer treatment.
Explore Oxford BioTherapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.
Other Startups in United Kingdom
Oxford Biomedicaseries-c-plusOxford BioelectronicsOxford Biodynamicsseries-aOxford Aviation AcademyOxehealthseries-aOxecoseries-aOxford Brain Diagnosticsseries-aOxford Cancer Biomarkersseries-aOxford Cannabinoid Technologiesseries-aOxford Drug Designseries-aOxford Dynamicsseries-aOxford Endovascularseries-a